Eszopiclone

CHEBI:CHEBI_53760

Definition

The (5S)- (active) enantiomer of zopiclone. Unlike almost all other hypnotic sedatives, which are approved only for the relief of short-term (6-8 weeks) insomnia, eszopiclone is approved by the U.S. Food and Drug Administration for long-term use.

Chemical Information

Molecular Formula
C17H17ClN6O3
Molecular Mass
388.80800
Charge
0
SMILES
CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)c2nccnc12)c1ccc(Cl)cn1
InChI
InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m0/s1
InChIKey
GBBSUAFBMRNDJC-INIZCTEOSA-N

Alternative Names

  • (+)-(5S)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methylpiperazine-1-carboxylate
  • (+)-Zopiclone
  • (5S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate
  • (S)-Zopiclone
  • Esopiclone
  • eszopiclone

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
461016
oboInOwl#hasDbXref
Wikipedia:Eszopiclone
core#notation
CHEBI:53760

Additional References

Wikipedia:Eszopiclone

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

chebi#is_enantiomer_of
http://purl.obolibrary.org/obo/CHEBI_53762
owl#annotatedSource
t245579
owl#someValuesFrom
t952282
listing_expiration_date
20241231
spl_id
dd7e4bab-8e25-4788-89e4-6b391f9596fe
marketing_start_date
20180518
package_description
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-067-30)
package_ndc
55111-619-09
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
labeler_name
St Mary's Medical Park Phcy
dosage_form
TABLET, COATED
application_number
ANDA091103
product_ndc
71610-409
route
OROPHARYNGEAL
manufacturer_name
St Mary's Medical Park Phcy
package_marketing_start_date
20080527
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
461016
oboInOwl#hasDbXref
Wikipedia:Eszopiclone
oboInOwl#id
CHEBI:53760
generic_name
ESZOPICLONE
brand_name
Lunesta
brand_name_base
Lunesta
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
core#notation
CHEBI:53760
dea_schedule
CIV
upc
0380725010301
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rxcui
540411
active_ingredient_name
ESZOPICLONE
active_ingredient_strength
15 kg/15kg
unii
UZX80K71OE
spl_set_id
dd7e4bab-8e25-4788-89e4-6b391f9596fe